Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTKB Cytek Biosciences	$3.10 -1.0%	$3.13	$2.37 ▼ $7.63	$396.44M	1.33	836,761 shs	429,296 shs
LAB Standard BioTools	$1.26 +2.4%	$1.14	$0.92 ▼ $2.41	$467.18M	1.54	1.91 million shs	1.12 million shs
SEER Seer	$2.13 +0.9%	$2.09	$1.59 ▼ $2.63	$124.21M	1.57	264,897 shs	56,911 shs
SENS Senseonics	$0.58 -0.4%	$0.52	$0.25 ▼ $1.40	$378.01M	0.92	7.41 million shs	9.35 million shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTKB Cytek Biosciences	-0.96%	-7.46%	+5.08%	-18.21%	-49.59%
LAB Standard BioTools	+2.44%	+0.80%	+20.00%	-0.79%	-42.47%
SEER Seer	+0.95%	0.00%	+5.97%	+1.91%	+18.33%
SENS Senseonics	-0.36%	+17.22%	+13.09%	-16.62%	+23.99%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CTKB Cytek Biosciences	3.228 of 5 stars	3.1	4.0	3.1	4.2	0.0
LAB Standard BioTools	3.9691 of 5 stars	3.5	4.0	3.9	3.3	1.3
SEER Seer	2.0766 of 5 stars	3.0	2.0	1.0	3.3	0.6
SENS Senseonics	2.3034 of 5 stars	3.8	1.0	3.8	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTKB Cytek Biosciences	2.20	Hold	$5.60	80.65% Upside
LAB Standard BioTools	3.00	Buy	$2.50	98.41% Upside
SEER Seer	2.00	Hold	$3.00	40.85% Upside
SENS Senseonics	3.50	Strong Buy	$1.55	168.26% Upside

Current Analyst Ratings Breakdown

Latest SEER, LAB, CTKB, and SENS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2025	LAB Standard BioTools	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/17/2025	SENS Senseonics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/15/2025	SENS Senseonics	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$1.25
7/8/2025	SENS Senseonics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$1.10 ➝ $1.40
6/2/2025	SENS Senseonics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy	$1.10
5/28/2025	CTKB Cytek Biosciences	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $7.00
5/12/2025	CTKB Cytek Biosciences	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sell ➝ Sell	$3.50 ➝ $3.00
5/9/2025	CTKB Cytek Biosciences	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$4.00

(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTKB Cytek Biosciences	$200.45M	1.96	$0.03 per share	90.20	$3.07 per share	1.01
LAB Standard BioTools	$174.43M	2.74	N/A	N/A	$1.27 per share	0.99
SEER Seer	$14.17M	8.85	N/A	N/A	$5.54 per share	0.38
SENS Senseonics	$23.68M	15.96	N/A	N/A	$0.07 per share	8.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTKB Cytek Biosciences	-$6.02M	-$0.09	N/A	∞	N/A	-5.71%	-2.90%	-2.30%	8/5/2025 (Estimated)
LAB Standard BioTools	-$138.88M	-$0.35	N/A	N/A	N/A	-78.24%	-22.44%	-16.74%	7/30/2025 (Estimated)
SEER Seer	-$86.60M	-$1.41	N/A	N/A	N/A	-560.90%	-24.69%	-22.13%	8/6/2025 (Estimated)
SENS Senseonics	-$60.39M	-$0.11	N/A	N/A	N/A	-362.30%	-842.25%	-67.99%	N/A

Latest SEER, LAB, CTKB, and SENS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	SEER Seer	-$0.39	N/A	N/A	N/A	N/A	N/A
8/5/2025	Q2 2025	CTKB Cytek Biosciences	-$0.02	N/A	N/A	N/A	$46.03 million	N/A
7/30/2025	Q2 2025	LAB Standard BioTools	-$0.04	N/A	N/A	N/A	$39.83 million	N/A
5/13/2025	Q1 2025	SEER Seer	-$0.37	-$0.34	+$0.03	-$0.34	$3.25 million	$4.21 million
5/8/2025	Q1 2025	CTKB Cytek Biosciences	-$0.04	-$0.09	-$0.05	-$0.09	$43.18 million	$41.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTKB Cytek Biosciences	N/A	N/A	N/A	N/A	N/A
LAB Standard BioTools	N/A	N/A	N/A	N/A	N/A
SEER Seer	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTKB Cytek Biosciences	N/A	5.62	4.95
LAB Standard BioTools	N/A	6.12	5.37
SEER Seer	N/A	19.34	18.81
SENS Senseonics	59.17	2.47	2.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTKB Cytek Biosciences	69.46%
LAB Standard BioTools	53.74%
SEER Seer	75.20%
SENS Senseonics	12.36%

Insider Ownership

Company	Insider Ownership
CTKB Cytek Biosciences	10.33%
LAB Standard BioTools	23.16%
SEER Seer	11.28%
SENS Senseonics	4.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTKB Cytek Biosciences	500	126.66 million	113.58 million	Optionable
LAB Standard BioTools	620	379.82 million	291.86 million	Optionable
SEER Seer	160	58.87 million	52.23 million	Optionable
SENS Senseonics	90	654.22 million	573.90 million	N/A

SEER, LAB, CTKB, and SENS Headlines

Recent News About These Companies

Senseonics (NYSE:SENS) Upgraded to "Strong-Buy" at Lake Street Capital

July 19 at 6:39 AM | marketbeat.com

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call ...

July 16, 2025 | gurufocus.com

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

July 16, 2025 | globenewswire.com

Brokers Set Expectations for Senseonics FY2027 Earnings

July 16, 2025 | marketbeat.com

Sequel Med Tech expects full twiist launch in the fall

July 15, 2025 | drugdeliverybusiness.comD

Senseonics (NYSE:SENS) Now Covered by Analysts at TD Cowen

July 15, 2025 | marketbeat.com

FY2028 EPS Estimates for Senseonics Boosted by HC Wainwright

July 15, 2025 | marketbeat.com

FY2026 EPS Estimates for Senseonics Boosted by HC Wainwright

July 11, 2025 | americanbankingnews.com

FY2026 EPS Estimates for Senseonics Raised by HC Wainwright

July 10, 2025 | marketbeat.com

New glucose sensors, insulin patch pumps lead ADA’s Scientific Sessions

July 3, 2025 | medtechdive.comM

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors

June 24, 2025 | medtechdive.comM

Senseonics lays out hopes for next-gen CGM commercial timelines

June 24, 2025 | drugdeliverybusiness.comD

Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks

June 18, 2025 | zacks.com

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

June 4, 2025 | globenewswire.com

Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories

May 21, 2025 | quiverquant.comQ

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025 | globenewswire.com

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

May 21, 2025 | seekingalpha.com

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025 | globenewswire.com

Senseonics opens $50M public offering, $25M private placement with Abbott

May 15, 2025 | drugdeliverybusiness.comD

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025 | globenewswire.com

Senseonics Holdings, Inc. (AMEX:SENS) Q1 2025 Earnings Call Transcript

May 9, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

2 Under the Radar Space & Defense Stocks With Huge Potential
By Leo Miller | July 1, 2025
View 2 Under the Radar Space & Defense Stocks With Huge Potential
Rocket Lab: Latest Catalysts Bolster the Bull Case
By Ryan Hasson | July 3, 2025
View Rocket Lab: Latest Catalysts Bolster the Bull Case
The Meteoric Rise of Rocket Lab: A Space Stock to Watch
By Ryan Hasson | July 11, 2025
View The Meteoric Rise of Rocket Lab: A Space Stock to Watch
Rocket Lab: Europe Comes Calling as Momentum Builds
By Ryan Hasson | June 27, 2025
View Rocket Lab: Europe Comes Calling as Momentum Builds
Rocket Lab Gets New Street-High Price Target from Citi
By Ryan Hasson | July 16, 2025
View Rocket Lab Gets New Street-High Price Target from Citi

SEER, LAB, CTKB, and SENS Company Descriptions

Cytek Biosciences NASDAQ:CTKB

$3.10 -0.03 (-0.96%)

Closing price 07/21/2025 04:00 PM Eastern

Extended Trading

$3.10 0.00 (0.00%)

As of 07/21/2025 06:00 PM Eastern

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Standard BioTools NASDAQ:LAB

$1.26 +0.03 (+2.44%)

Closing price 07/21/2025 04:00 PM Eastern

Extended Trading

$1.25 -0.01 (-1.19%)

As of 07/21/2025 07:56 PM Eastern

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Seer NASDAQ:SEER

$2.13 +0.02 (+0.95%)

Closing price 07/21/2025 04:00 PM Eastern

Extended Trading

$2.13 +0.00 (+0.23%)

As of 07/21/2025 04:04 PM Eastern

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Senseonics NYSE:SENS

$0.58 0.00 (-0.36%)

Closing price 07/21/2025 04:00 PM Eastern

Extended Trading

$0.58 +0.00 (+0.03%)

As of 07/21/2025 08:00 PM Eastern

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time